CASP1 and acute coronary syndrome: Robertson Robertson S S Martínez Martínez GJ GJ Payet Payet CA CA Barraclough Barraclough JY JY Celermajer Celermajer DS DS Bursill Bursill C C Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation Clin Sci Clin Sci 2016 2016 130 130 14 14 1237 1237 1246 1246 10.1042/CS20160090 10.1042/CS20160090 Robertson S, Martínez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, et al.